Effects of Walking and Heating on Vascular Function in Diabetic Patients
Restoring Vasodilator Actions of Insulin in Patients With Type 2 Diabetes
1 other identifier
interventional
99
1 country
1
Brief Summary
The purpose of the present study is to determine the effects of increased walking and lower body heating on leg vascular function in patients with type 2 diabetes (T2D).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable type-2-diabetes-mellitus
Started Dec 2017
Longer than P75 for not_applicable type-2-diabetes-mellitus
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 23, 2017
CompletedFirst Posted
Study publicly available on registry
June 29, 2017
CompletedStudy Start
First participant enrolled
December 4, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 10, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
March 10, 2022
CompletedResults Posted
Study results publicly available
April 4, 2024
CompletedApril 4, 2024
April 1, 2024
4.3 years
June 23, 2017
September 28, 2023
April 1, 2024
Conditions
Outcome Measures
Primary Outcomes (2)
Insulin-stimulated Leg Blood Flow Calculated as Percent Change (t0, t60)
Measure of blood flow in response to insulin. Blood flow is measured via Doppler ultrasound at the femoral artery. Measurements are performed at baseline (t0) and after 60 minutes of insulin stimulation (t60).
Percent change from baseline leg blood flow during 60 minutes of insulin stimulation.
Net Change in Insulin-stimulated Leg Blood Flow Calculated as Percent Change From Pre-intervention (t0,t60) to Post-intervention (t0,t60).
Measure of blood flow in response to insulin. Blood flow is measured via Doppler ultrasound at the femoral artery. Measurements are performed pre-intervention and post-intervention at baseline (t0) and after 60 minutes of insulin stimulation (t60). Outcome measure indicates whether percent change in insulin-stimulated blood flow increased or decreased following intervention. Interventions that show an increase demonstrate an improvement in insulin-stimulated blood flow.
Change from baseline insulin-stimulated leg blood flow following 1 heating session, 7 days of heating intervention, or 8 weeks of walking intervention/no intervention.
Study Arms (6)
Walking: Intervention arm in diabetics
EXPERIMENTALThe walking program will consist of 45 minutes of walking (at a moderate pace) 5 days per week for 8 weeks.
Walking: No intervention in diabetics
EXPERIMENTALSubjects will be instructed to continue their usual lifestyle for 8 weeks.
Walking: Healthy cohort as reference controls
OTHERSubjects will be studied at one time only.
Lower body heating: Intervention arm in healthy subjects
EXPERIMENTALThis intervention consists of 60 minutes of lower body heating (40-42 degree C).
Lower body heating: Intervention arm in diabetics
EXPERIMENTALThis intervention consists of 60 minutes of lower body heating (40-42 degree C) 7 days per week for 7 days.
Lower body heating: Healthy cohort as reference controls
OTHERSubjects will be studied at one time only.
Interventions
The walking program will consist of 45 minutes of walking (at a moderate pace) 5 days per week for 8 weeks.
Subjects will be instructed to continue their usual lifestyle for 8 weeks.
Subjects will be studied at one time only.
This intervention consists of 60 minutes of lower body heating (40-42 degree C).
This intervention consists of 60 minutes of lower body heating (40-42 degree C) 7 days per week for 7 days.
Subjects will be studied at one time only.
Eligibility Criteria
You may qualify if:
- Patients with type 2 diabetes who are overweight and obese (BMI 25-50 kg/m2), 35 to 65 years of age, and sedentary (\<60 minutes structured exercise/week). Healthy volunteers without type 2 diabetes: 18 to 65 years of age.
You may not qualify if:
- Cardiovascular disease including myocardial infraction, heart failure, coronary artery disease, stroke;
- renal or hepatic diseases;
- active cancer;
- autoimmune diseases;
- immunosuppressant therapy;
- excessive alcohol consumption (\>14 drinks/week for men; \>7 drinks/week for women);
- current tobacco use;
- pregnancy;
- mobility limitations;
- foot ulcers;
- diabetic neuropathy
- uncontrolled hypertension (\>=180 systolic / 100 diastolic mmHg)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Missouri
Columbia, Missouri, 65212, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Jaume Padilla
- Organization
- University of Missouri
Study Officials
- PRINCIPAL INVESTIGATOR
Jaume Padilla, PhD
University of Missouri-Columbia
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
June 23, 2017
First Posted
June 29, 2017
Study Start
December 4, 2017
Primary Completion
March 10, 2022
Study Completion
March 10, 2022
Last Updated
April 4, 2024
Results First Posted
April 4, 2024
Record last verified: 2024-04
Data Sharing
- IPD Sharing
- Will not share